| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |